Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR 77.00
+1.34 (1.77%)
Nov 11, 2026, 3:29 PM IST
NSE:NIVABUPA Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NSE:NIVABUPA stock has a consensus rating of "Buy" and an average price target of ₹96.09. The average 1-year stock price forecast is 24.79% higher than the current stock price, while the lowest is ₹85.00 (+10.39%) and the highest is ₹105.00 (+36.36%).
Price Target: ₹96.09 (+24.79%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Oct 8, 2026.
Analyst Ratings
The average analyst rating for NSE:NIVABUPA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 5 |
| Buy | 6 | 6 | 7 | 7 | 7 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹105.00 → ₹95.00 | Buy | Maintains | ₹105.00 → ₹95.00 | +23.38% | Oct 8, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Maintains ₹100.00 | Buy | Maintains | ₹100.00 | +29.87% | Sep 24, 2026 |
Financial Forecast
Revenue This Year
98.63B
from 84.43B
Increased by 16.82%
Revenue Next Year
121.00B
from 98.63B
Increased by 22.68%
EPS This Year
2.70
from 0.71
Increased by 280.14%
EPS Next Year
3.41
from 2.70
Increased by 26.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.